All conference submissions

The growing adoption of Digital Twin (DT) technologies in healthcare highlights the need to define how medical imaging tools (physical and digital phantoms, real and simulated CT studies, etc.) integrate with the virtual componen...

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Nanoparticle-mediated radiation therapy (NPRT) is an emerging clinical research frontier which seeks to improve radiotherapy outcomes through local tumor dose enhancement and radiosensitization. We recently showed improved NPRT o...

Standard dose optimization fails in low-resource settings due to unique patient phenotypes, heterogeneous aging equipment, and absent validation pathways. This work presents a closed-loop digital twin ecosystem that autonomously...

Describe highlights of organizational changes that allowed for the ramp-up of the radiopharmaceutical trials program at the University of Miami Health System (UHealth)

Rectal spacers are widely used in prostate stereotactic ablative radiotherapy (SAbR) to reduce rectal dose; however, their value as a practical, planning-oriented QA tool remains underdefined. Using real-world clinical trial data...

Total body irradiation (TBI) is a well-established conditioning regimen prior to hematopoietic stem cell transplant (HSCT) for treatment of leukemia cancers. This study reports on a Central-Asian national referral cancer centre’s...

To validate the accuracy of CuraProton, a newly developed proton therapy treatment planning system, through comprehensive type testing of depth dose distributions and transverse dose profiles across multiple clinically complex sc...

The clinical translation of ultra-high dose rate (FLASH) radiotherapy is hindered by an incomplete understanding of the physical parameter space required to optimize normal tissue sparing. This study utilizes a human bone marrow-...

Big-data radiotherapy research faces challenges in achieving consistent structure nomenclature across large hospital networks. This study develops and validates a novel automated pipeline for standardizing structure names. Our mu...

IROC and Radiation Quality Assurance Lab monitor more than 2500 radiotherapy facilities worldwide to ensure accurate and consistent radiotherapy delivery. This study reviews the 30 year history of the anthropomorphic phantom prog...

Given the significant rise in patients receiving 50-cGy x 6 fractions low dose radiation therapy (LDRT) of osteoarthritis (OA), we evaluate this emerging treatment technique.

This scoping review aims to synthesize and visually map the extant evidence on trigeminal neuralgia (TN) treatments over the past decade, thereby elucidating the evolving therapeutic landscape. It seeks to identify prevailing res...

To design and validate reliable treatment planning and delivery verification methods for TMPRT in the phase III NRG CC-017 trial, which compares TMPRT to standard radiotherapy in adults with newly diagnosed MGMT-unmethylated glio...

To design an anthropomorphic phantom that closely mimics a clinical brain metastases patient to assess the end-to-end performance of multi-lesion SRS treatments.

Approximately 80% of clinically actionable oncology data remains siloed in unstructured formats, including clinical narratives and pathology reports. This study validates an end-to-end Natural Language Processing (NLP) pipeline f...

Clinical trials require the extraction of specific metrics from DICOM plan datasets for protocol-driven data analysis. Because these metrics vary widely across trials, it has been difficult to develop an automated system capable...

Dose-volume constraints for organs at risk (OARs) in stereotactic body radiation therapy (SBRT) for thoracic cancer patients have been well established through multiple prospective clinical trials. However, during equivalent dose...

Portal hypertension (PH) is currently diagnosed by the hepatic venous pressure gradient (HVPG). Subharmonic imaging (SHI) is a contrast-enhanced ultrasound (CEUS) imaging technique receiving at half the transmit frequency resulti...

To develop risk-stratification and prognosis-prediction models for limited-stage small cell lung cancer (LS-SCLC) patients, suggesting potential candidates that may benefit from the new treatment protocol using high-dose hyperfra...

Glioblastoma is highly aggressive and the most prevalent brain tumor in adults. The median survival of patients is 15 months, despite the current standard of care comprising surgery, radiotherapy, and chemotherapy. Hence, new the...

Gold nanoparticles (GNPs) are promising radiosensitizing agents for high dose rate brachytherapy (HDR); however, complex treatment delivery for HDR has prohibited systematic evaluation of GNP-induced radiosensitization both in vi...

To determine which cardiac substructures are associated with radiation-induced cardiac symptoms following radiotherapy for stage III non-small cell lung cancer (NSCLC), and to estimate the corresponding dose–response relationship...

Radiotherapy quality assurance (RTQA) of target volume delineation is critical in clinical trials to ensure protocol adherence. Manual real-time review is resource-intensive and often limited to a subset of patients. This study e...